Vivos (RDGL) Gross Margin (2010 - 2025)

Vivos (RDGL) reported Gross Margin of 12.54% for Q4 2025, up 9326.0% on a YoY basis from 0.13% in Q4 2024, and up 98.16% sequentially from 682.01% in Q3 2025.

Vivos (RDGL) Gross Margin (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 11 years of Gross Margin data on file, last reported at 12.54% in Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 9326.0% year-over-year to 12.54%; the trailing twelve-month figure through Dec 2025 stood at 87.39% (down 7673.0% YoY), and the FY2025 full-year result was 87.39%, down 7673.0% from the prior year.
  • Gross Margin advanced to 12.54% in Q4 2025, from 682.01% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q3 2023 to a low of 682.01% in Q3 2025.
  • A 5-year average of 60.61% and a median of 29.47% in 2023 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin jumped 20054 bps in 2023 and plunged 70363 bps in 2025, its largest moves.
  • Tracing RDGL's Gross Margin over 5 years: stood at 59.7% in 2021, then slumped by 209 bps to 65.04% in 2022, then surged by 254 bps to 100.0% in 2023, then plunged by 206 bps to 105.81% in 2024, then surged by 88 bps to 12.54% in 2025.
  • Business Quant data shows RDGL's Gross Margin at 12.54% in Q4 2025, 682.01% in Q3 2025, and 231.69% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 56.20%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 63.29%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 65.35%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 78.01%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 62.95%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 38.53%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 45.22%
10 Vivos 27.16 Mn 25.60 Mn -3,105.00 -12.54%

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.54%
Sep 30, 2025 -682.01%
Jun 30, 2025 -231.69%
Mar 31, 2025 -33.96%
Dec 31, 2024 -105.81%
Sep 30, 2024 21.62%
Jun 30, 2024 20.15%
Mar 31, 2024 -33.33%
Sep 30, 2023 100.00%
Jun 30, 2023 -38.46%
Mar 31, 2023 -25.60%
Dec 31, 2022 -65.04%
Sep 30, 2022 -100.54%
Jun 30, 2022 80.78%
Mar 31, 2022 76.92%
Sep 30, 2021 59.70%
Sep 30, 2015 99.99%
Mar 31, 2015 96.76%
Jun 30, 2014 97.01%
Mar 31, 2014 98.21%